Men Using Ozempic and Wegovy Face 40% Increased Risk of Hair Loss
Dermatologists report a 40% increase in hair loss risk linked to GLP-1 medications, prompting concerns among patients using these popular weight-loss drugs.
Weekly curated summaries of the latest hair loss research and treatment news. Stay informed about breakthroughs, clinical trials, and expert insights.
Real user experiences with hair loss treatments. Browse ratings from our community.
FDA-approved oral medication that blocks the conversion of testosterone to DHT, the hormone responsible for male pattern baldness.
FDA-approved topical solution or foam that promotes hair growth by prolonging the anagen (growth) phase of hair follicles.
Off-label oral formulation of minoxidil, originally developed as a blood pressure medication, now used in low doses for hair loss.
Access cutting-edge treatments before they're widely available. Our Clinical Trial Matcher finds recruiting trials near you in under 2 minutes.
Dermatologists report a 40% increase in hair loss risk linked to GLP-1 medications, prompting concerns among patients using these popular weight-loss drugs.
Dermatologists report that oral minoxidil, traditionally used for hypertension, shows promising results for hair regrowth, with a 70% success rate in some patients.
A systematic review highlights the potential of Janus kinase inhibitors in treating lichen planus, a condition that can lead to hair loss, suggesting new avenues for patients seeking relief.
Get answers to frequently asked questions about hair loss research, treatments, and our digest.
Get comprehensive summaries of the latest hair loss research every week.
All summaries cite original sources from PubMed and reputable news outlets.
Never miss important breakthroughs in hair loss research and treatments.